In light of the multi-stakeholder hearings on TB, PPR, and UHC that took place between the 8-9th of May and the release of the zero drafts for the HLM on TB and on UHC, STOPAIDS and partners have released a series of briefings for advocates participating in the upcoming negotiations for the political declarations and … Continued
This report, part of the Access Denied series, explores the role that UK public entities have played in supporting the development of COVID-19 tools such as diagnostics, vaccines and treatments. It highlights how the lack of equitable access safeguards across the research and development (R&D) continuum results in the perpetuation of an extractive global health … Continued
Three years on, the COVID-19 pandemic has officially caused the deaths of over 7 million people, disrupting livelihoods globally and continuing to have a devastating impact on communities that don’t have widespread access to health technologies. The world’s response to the pandemic has demonstrated the flaws in the existing global system for the research, development … Continued
STOPAIDS and Global Health Advocates’ report series ‘Access Denied‘ explores how a lack of transparency in the pharmaceutical industry and the EU has harmed public health outcomes. The series is structured into two reports. The first set the scene through speaking to key actors and stakeholders who were involved in or following the contract negotiations. In … Continued
This report investigates how young adults in Ghana, Kenya and Vietnam experience the digital transformation in health, and what they see as the effect on their human rights. In particular, the study explores the tensions between the benefits and risks to young peoples’ right to health and other human rights, and identifies areas for … Continued
STOPAIDS and other organisations have produced a briefing asking the UK to step up it’s leadership to end epidemics through investing in the Global Fund To Fight AIDS, TB and Malaria. The target for the Global Fund’s Seventh Replenishment is to raise at least US$18 billion to get the world back on track toward ending HIV, TB … Continued
This report follows the inquiry conducted by the APPG on HIV, STOPAIDS and Frontline AIDS on the impact of the ODA cuts on the HIV response. Through exploring case studies of UK Aid- funded multilateral, bilateral and research projects, it analyses how crucial organisations, people living with HIV and the HIV response are being affected … Continued
It is increasingly acknowledged that mental health is a risk factor for HIV and TB and can negatively impact on the course of the disease and treatment, and that living with HIV and/ or TB is a significant risk factor for a decline in an individual’s mental health and developing psychiatric illness. The findings of … Continued
Since the creation of the Global Fund to Fight AIDS, TB and Malaria (Global Fund) in 2002, nearly 20 years ago, the UK has been a leading donor and partner. In this time the Global Fund has showcased what is possible when governments, civil society and private sector stakeholders come together to achieve progress. … Continued
The aim of this paper, developed by STOPAIDS, Aidsfonds, Civil Society Sustainability Network and Frontline AIDS, is to serve as a catalyst for discussion within civil society on how the global health architecture of the Universal Health Coverage era should evolve and how it should be governed drawing on lessons from the global HIV response. … Continued